Localization of precursor proteins and mRNA of type I and III collagens in usual interstitial pneumonia and sarcoidosis

Journal of Molecular Histology

Volumn 36, Issue 6-7, 2005, Pages 437-446

  Kaarteenaho Wiik, Riitta ^a   Lammi, Lauri ^b   Lakari, Essi ^a   Kinnula, Vuokko L ^c   Risteli, Juha ^a   Ryhänen, Lasse ^a   Pääkkö, Paavo ^a  

^a UNIVERSITY OF OULU   (Finland)

^b JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COLLAGEN TYPE 1; COLLAGEN TYPE 3; MESSENGER RNA; PEPTIDE; PROCOLLAGEN C PROTEINASE; PROCOLLAGEN N PROTEINASE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; PROTEIN PRECURSOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GRANULOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS EPITHELIUM; LUNG BIOPSY; LUNG FIBROSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; SARCOIDOSIS;

COLLAGEN TYPE I; COLLAGEN TYPE III; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG DISEASES, INTERSTITIAL; PROTEIN PRECURSORS; PROTEIN TRANSPORT; PULMONARY ALVEOLI; RNA, MESSENGER; SARCOIDOSIS;

EID: 33646891728     PISSN: 15672379     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10735-006-9018-9     Document Type: Article

References (53)

1. Bateman ED, Turner-Warwick M, Adelmann-Grill BC (1981) Immunohistochemical study of collagen types in human foetal lung and fibrotic lung disease. Thorax 36: 645-653.
2. Bensadoun ES, Burge AK, Hogg JC, Roberts CR (1996) Proteoglycan deposition in pulmonary fibrosis. Am J Respir Crit Care Med 154: 1819-1828.
3. Bernard MB, Myers JC, Chu M-L, Ramirez F, Eikenberry EF, Prockop DJ (1983) Structure of a cDNA for the proα2 chain of human type I procollagen: comparison with chick cDNA for proα2(I) identifies structurally conserved features of the protein and the gene. Biochemistry 22: 1139-1145.
4. Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, Offord KP (1998) Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 157: 199-203.
5. Budinger GRS, Chandel NS, Donnelly HK, Eisenbart J, Oberoi M, Jain M (2005) Active transforming growth factor-β1 activates the procollagen I promoter in patients with acute lung injury. Intensive Care Med 31: 121-128.
6. Dail DH, Hammar SP (1994) Pulmonary Pathology (2nd ed.). Springer-Verlag, New York, pp 1-19 597-678.
7. Du W-D, Zhang Y-E, Zhai W-R, Zhou X-M (1999) Dynamic changes of type I, III and IV collagen synthesis and distribution of collagen producing cells in carbon tetrachloride-indiced rat liver fibrosis. WJG 5: 397-403.
8. Fine A, Poliks CF, Smith BD, Goldstein RH (1990) The accumulation of type I collagen mRNAs in human embryonic lung fibroblasts stimulated by transforming growth factor beta. Connect Tissue Res 24: 237-247.
9. Fujita J, Ohtsuki Y, Suemitsu I, Yamadori I, Shigeto E, Shiode M, Nishimura K, Hirayama T, Matsushima T, Ishida T (2002) Immunohistochemical distribution of epithelioid cell, myofibroblats, and transforming growth factor-β1 in the granuloma caused by mycobacterium avium intracellulare complex pulmonary infection. Microbiol Immunol 46: 67-74.
10. Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N (1998) Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab Invest 78: 678-698.
11. Garcia CSNB, Rocco PR, Facchinetti LD, Lassance RM, Caruso P, Deheinzelin D, Morales MM, Romero PV, Faffe DS, Zin WA (2004) What increases type III procollagen mRNA levels in lung tissue: stress induced by changes in force or amplitude?. Respir Physiol Neurobiol 144: 59-70.
12. Horino Y, Takahashi S, Miura T, Takahashi Y (2002) Prolonged hypoxia accelerated the posttranscriptional process of collagen synthesis in cultured fibroblasts. Life Sci 71: 3031-3045.
13. Ignotz RA, Endo T, Massague J (1987) Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. J Biol Chem 262: 6443-6446.
14. Kaarteenaho-Wiik R, Tani T, Sormunen R, Soini Y, Virtanen I, Pääkkö P (1996) Tenascin immunoreactivity as a prognostic marker in usual interstitial pneumonia. Am J Respir Crit Care Med 154: 511-518.
15. Kaarteenaho-Wiik R, Kinnula VL, Herva R, Pääkkö P, Pöllänen R, Soini Y (2001) Distribution and mRNA expression of tenascin-C in developing human lung. Am J Respir Cell Mol Biol 25: 341-346.
16. Kaarteenaho-Wiik R, Pääkkö P, Herva R, Risteli J, Soini Y (2004) Type I and III collagen protein precursors and mRNA in the developing human lung. J Pathol 203: 567-574.
17. Katzenstein A-LA (1997) Katzenstein and Askin's Surgical Pathology of Non-neoplastic Lung Disease. W.B. Saunders Company, Philadelphia, pp 48-80.
18. Katzenstein A-LA, Myers JL (1998) Idiopathic pulmonary fibrosis: Clinical relevance of pathologic classification. Am J Respir Crit Care Med 157: 1301-1315.
19. Kauppila S, Stenbäck F, Risteli J, Jukkola A, Risteli L (1998) Aberrant type I and III collagen gene expression in human breast cancer in vivo. J Pathol 186: 262-268.
20. Kuhn C, Boldt J, King TE, Crouch E, Vartio T, McDonald JA (1989) An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 140: 1693-1703.
21. Kuhn C, McDonald JA (1991) The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol 138: 1257-1265.
22. Kuivaniemi H, Tromp G, Chu M-L, Prockop DJ (1988) Structure of a full length cDNA clone for the preproα2(I) chain of human type I procollagen. Biochem J 252: 633-640.
23. Lammi L, Kinnula V, Lähde S, Risteli J, Pääkkö P, Lakari E, Ryhänen L (1997) Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. Eur Respir J 10: 2725-2730.
24. Lammi L, Ryhänen L, Lakari E, Risteli J, Pääkkö P, Kahlos K, Lähde S, Kinnula V (1999) Type III and type I procollagen markers in fibrosing alveolitis. Am J Respir Crit Care Med 159: 818-823.
25. Laurent GJ (1986) Lung collagen: more than scaffolding. Thorax (Review article) 41: 418-428.
26. Loidl HR, Brinker JM, May M, Pihlajaniemi T, Morrow S, Rosenbloom J, Myers JC (1984) Molecular cloning and carboxyl-propeptide analysis of human type III procollagen. Nucleic Acids Res 12: 9383-9394.
27. McAnulty RJ, Campa JS, Cambrey AD, Laurent GJ (1991) The effect of growth factor beta on rates of procollagen synthesis and degradation in vitro. Biochim Biophys Acta 1091: 231-235.
28. Melkko J, Kauppila S, Niemi S, Risteli L, Haukipuro K, Jukkola A, Risteli J (1996) Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem 42: 947-954.
29. Miyahara M, Njieha FK, Prockop DJ (1982) Formation of collagen fibrils in vitro by cleavage of procollagen with procollagen proteinases. J Biol Chem 257: 8442-8448.
30. Mäkelä JK, Raassina M, Virta A, Vuorio E (1988) Human proα(I) collagen: cDNA sequence for the C-propeptide domain. Nucleic Acid Res 16: 349.
31. Niemelä O, Risteli L, Parkkinen J, Risteli J (1985) Purification and characterization of the aminoterminal propeptide of human type III procollagen. Biochem J 232: 145-150.
32. Ohta K, Mortenson RL, Clark RA, Hirose N, King TE (1995) Immunohistochemical identification and characterization of smooth muscle-like cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 152: 1659-1665.
33. Pardo A, Selman M, Ramirez R, Ramos C, Montano M, Sricklin G, Raghu G (1992) Production of collagenase and tissue inhibitor of metalloproteinases by fibroblasts derived from normal and fibrotic human lungs. Chest 102: 1085-1089.
34. Prockop DJ, Kivirikko KI, Tuderman L, Guzman NA (1979) The biosynthesis of collagen and its disorders. N Engl J Med (Review) 301: 13-23.
35. Pääkkö P, Nuorva K, Kamel D, Soini Y (1992) Evidence by in situ hybridization that c-erbB-2 proto-oncogene expression is a marker of malignancy and is expressed in lung adenocarcinomas. Am J Respir Cell Mol Biol 7: 325-334.
36. Raghu G, Striker LJ, Hudson LD, Striker GE (1985) Extracellular matrix in normal and fibrotic human lungs. Am Rev Respir Dis 131: 281-289.
37. Ramos DM, Chen BL, Boylen K, Stern M, Kramer RH, Sheppard D, Nishimura SL, Greenspan D, Zardi L, Pytela R (1997) Stromal fibroblasts influence oral squamous-cell carcinoma cell interactions with tenascin-C. Int J Cancer 72: 369-376.
38. Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat AP, Risteli L (1988) Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 34: 715-718.
39. Risteli L, Risteli J (1990) Non-invasive methods for detection of organ fibrosis. In: Rojkind M, et al., eds. Connective Tissue in Health and Disease. Boca Raton: CRC Press, pp. 61-98, 32.
40. Roman J, Jeon Y-J, Gal A, Perez RL (1995) Distribution of extracellular matrices, matrix receptors, and transforming growth factor-β1 in human and experimental lung granulomatous inflammation. Am J Med Sci 309: 124-133.
41. Rosenfeld MA, Siegfrid W, Yoshimura K, et al. (1991) Adenovirus-mediated transfer of a recombinant α1-antitrypsin gene to the lung epithelium in vivo. Science 252: 431-434.
42. Sakai T, Kawakatsu H, Ohta M, Saito M (1994) Tenascin induction in tenascin nonproducing carcinoma cell lines in vivo and by TGF-β in vitro. J Cell Phys 159: 561-572.
43. Saldiva PHN, Delmonte VC, de Carvalho CRR, Kairalla RA, Auler JOC Jr. (1989) Histochemical evaluation of lung collagen content in acute and chronic interstitial diseases. Chest 95: 953-957.
44. Selman M, Montano M, Ramos C, Chapela R (1986) Concentration, biosynthesis and degradation of collagen in idiopathic pulmonary fibrosis. Thorax 41: 355-359.
45. Specks U, Nerlich A, Colby TV, Wiest I, Timpl R (1995) Increased expression of type VI collagen in lung fibrosis. Am J Respir Crit Care Med 151: 1956-1964.
46. Thurlbeck WM, Churg AM (1995) Pathology of the Lung (1st ed.). Thieme, New York, pp 589-737.
47. Torikata C, Villiger B, Kuhn C, McDonald JA (1985) Ultrastructural distribution of fibronectin in normal and fibrotic human lung. Lab Invest 52: 399-308.
48. Vuorio T, Mäkelä JK, Kähäri V-M, Vuorio E (1987) Coordinated regulation of type I and type III collagen production and mRNA levels of proα1(I) and of proα2(I) collagen in cultured morphea fibroblasts. Arch Dermatol Res 279: 154-160.
49. Wageenvort CA (1980) Lung biopsy specimens in the evaluation of pulmonary vascular disease. Chest 77: 614-625.
50. Zhang K, Rekhter MD, Gordon D, Phan SH (1994) Myofibroblats and their role in lung collagen gene expression during pulmonary fibrosis. Am J Pathol 145: 114-125.
51. Zhang K, Flanders KC, Phan SH (1995) Cellular localization of transforming growth factor-β expression in bleomycin-induced pulmonary fibrosis. Am J Pathol 147: 352-361.
52. Zhu G-G, Stenbäck F, Risteli L, Risteli J, Kauppila A (1993) Organization of type III collagen in benign and malignat ovarian tumors. Cancer 72: 1679-1684.
53. Zhu G-G, Risteli L, Mäkinen M, Risteli J, Kauppila A, Stenbäck F (1995) Immunohistochemical study of type I collagen and type I pN-collagen in benign and malignant ovarian neoplasms. Cancer 75: 1010-1017.